Literature DB >> 27852852

Ablation of Programmed -1 Ribosomal Frameshifting in Venezuelan Equine Encephalitis Virus Results in Attenuated Neuropathogenicity.

Joseph A Kendra1, Cynthia de la Fuente2, Ashwini Brahms2, Caitlin Woodson2, Todd M Bell2, Bin Chen1, Yousuf A Khan1, Jonathan L Jacobs3, Kylene Kehn-Hall4, Jonathan D Dinman5.   

Abstract

The alphaviruses Venezuelan equine encephalitis virus (VEEV), eastern equine encephalitis virus (EEEV), and western equine encephalitis virus (WEEV) are arthropod-borne positive-strand RNA viruses that are capable of causing acute and fatal encephalitis in many mammals, including humans. VEEV was weaponized during the Cold War and is recognized as a select agent. Currently, there are no FDA-approved vaccines or therapeutics for these viruses. The spread of VEEV and other members of this family due to climate change-mediated vector range expansion underscores the need for research aimed at developing medical countermeasures. These viruses utilize programmed -1 ribosomal frameshifting (-1 PRF) to synthesize the viral trans-frame (TF) protein, which has previously been shown to be important for neuropathogenesis in the related Sindbis virus. Here, the alphavirus -1 PRF signals were characterized, revealing novel -1 PRF stimulatory structures. -1 PRF attenuation mildly affected the kinetics of VEEV accumulation in cultured cells but strongly inhibited its pathogenesis in an aerosol infection mouse model. Importantly, the decreased viral titers in the brains of mice infected with the mutant virus suggest that the alphavirus TF protein is important for passage through the blood-brain barrier and/or for neuroinvasiveness. These findings suggest a novel approach to the development of safe and effective live attenuated vaccines directed against VEEV and perhaps other closely related -1 PRF-utilizing viruses. IMPORTANCE: Venezuelan equine encephalitis virus (VEEV) is a select agent that has been weaponized. This arthropod-borne positive-strand RNA virus causes acute and fatal encephalitis in many mammals, including humans. There is no vaccine or other approved therapeutic. VEEV and related alphaviruses utilize programmed -1 ribosomal frameshifting (-1 PRF) to synthesize the viral trans-frame (TF) protein, which is important for neuropathogenesis. -1 PRF attenuation strongly inhibited VEEV pathogenesis in mice, and viral replication analyses suggest that the TF protein is critical for neurological disease. These findings suggest a new approach to the development of safe and effective live attenuated vaccines directed against VEEV and other related viruses.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  alphavirus; neuropathology; ribosomal frameshifting; vaccine; virus

Mesh:

Substances:

Year:  2017        PMID: 27852852      PMCID: PMC5244343          DOI: 10.1128/JVI.01766-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  NUPACK: Analysis and design of nucleic acid systems.

Authors:  Joseph N Zadeh; Conrad D Steenberg; Justin S Bois; Brian R Wolfe; Marshall B Pierce; Asif R Khan; Robert M Dirks; Niles A Pierce
Journal:  J Comput Chem       Date:  2011-01-15       Impact factor: 3.376

3.  Importance of ribosomal frameshifting for human immunodeficiency virus type 1 particle assembly and replication.

Authors:  M Hung; P Patel; S Davis; S R Green
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

Review 4.  Ribosomal frameshifting viral RNAs.

Authors:  I Brierley
Journal:  J Gen Virol       Date:  1995-08       Impact factor: 3.891

5.  Effects of an In-Frame Deletion of the 6k Gene Locus from the Genome of Ross River Virus.

Authors:  Adam Taylor; Julian V Melton; Lara J Herrero; Bastian Thaa; Liis Karo-Astover; Peter W Gage; Michelle A Nelson; Kuo-Ching Sheng; Brett A Lidbury; Gary D Ewart; Gerald M McInerney; Andres Merits; Suresh Mahalingam
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

Review 6.  Encephalitic alphaviruses.

Authors:  Michele A Zacks; Slobodan Paessler
Journal:  Vet Microbiol       Date:  2009-08-28       Impact factor: 3.293

7.  NS1' colocalizes with NS1 and can substitute for NS1 in West Nile virus replication.

Authors:  Lucy B Young; Ezequiel Balmori Melian; Alexander A Khromykh
Journal:  J Virol       Date:  2013-06-12       Impact factor: 5.103

8.  Functional characterization of the alphavirus TF protein.

Authors:  Jonathan E Snyder; Kirsten A Kulcsar; Kimberly L W Schultz; Catherine P Riley; Jacob T Neary; Scott Marr; Joyce Jose; Diane E Griffin; Richard J Kuhn
Journal:  J Virol       Date:  2013-05-29       Impact factor: 5.103

9.  Systematic analysis of bicistronic reporter assay data.

Authors:  Jonathan L Jacobs; Jonathan D Dinman
Journal:  Nucleic Acids Res       Date:  2004-11-23       Impact factor: 16.971

10.  Programmed ribosomal frameshift alters expression of west nile virus genes and facilitates virus replication in birds and mosquitoes.

Authors:  Ezequiel Balmori Melian; Sonja Hall-Mendelin; Fangyao Du; Nick Owens; Angela M Bosco-Lauth; Tomoko Nagasaki; Stephen Rudd; Aaron C Brault; Richard A Bowen; Roy A Hall; Andrew F van den Hurk; Alexander A Khromykh
Journal:  PLoS Pathog       Date:  2014-11-06       Impact factor: 6.823

View more
  20 in total

1.  Structural divergence creates new functional features in alphavirus genomes.

Authors:  Katrina M Kutchko; Emily A Madden; Clayton Morrison; Kenneth S Plante; Wes Sanders; Heather A Vincent; Marta C Cruz Cisneros; Kristin M Long; Nathaniel J Moorman; Mark T Heise; Alain Laederach
Journal:  Nucleic Acids Res       Date:  2018-04-20       Impact factor: 16.971

Review 2.  Revisiting an old friend: new findings in alphavirus structure and assembly.

Authors:  Julie M Button; Shefah A Qazi; Joseph Che-Yen Wang; Suchetana Mukhopadhyay
Journal:  Curr Opin Virol       Date:  2020-07-16       Impact factor: 7.090

Review 3.  Emergency Services of Viral RNAs: Repair and Remodeling.

Authors:  Vadim I Agol; Anatoly P Gmyl
Journal:  Microbiol Mol Biol Rev       Date:  2018-03-14       Impact factor: 11.056

4.  Complex dynamics under tension in a high-efficiency frameshift stimulatory structure.

Authors:  Matthew T J Halma; Dustin B Ritchie; Tonia R Cappellano; Krishna Neupane; Michael T Woodside
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-13       Impact factor: 11.205

5.  TF protein of Sindbis virus antagonizes host type I interferon responses in a palmitoylation-dependent manner.

Authors:  K J Rogers; S Jones-Burrage; W Maury; S Mukhopadhyay
Journal:  Virology       Date:  2020-01-07       Impact factor: 3.616

Review 6.  Regulators of Viral Frameshifting: More Than RNA Influences Translation Events.

Authors:  Wesley D Penn; Haley R Harrington; Jonathan P Schlebach; Suchetana Mukhopadhyay
Journal:  Annu Rev Virol       Date:  2020-06-29       Impact factor: 10.431

Review 7.  Translation Elongation and Recoding in Eukaryotes.

Authors:  Thomas E Dever; Jonathan D Dinman; Rachel Green
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-08-01       Impact factor: 10.005

8.  Functional and structural characterization of the chikungunya virus translational recoding signals.

Authors:  Joseph A Kendra; Vivek M Advani; Bin Chen; Joseph W Briggs; Jinyi Zhu; Hannah J Bress; Sushrut M Pathy; Jonathan D Dinman
Journal:  J Biol Chem       Date:  2018-09-21       Impact factor: 5.157

9.  PERK Is Critical for Alphavirus Nonstructural Protein Translation.

Authors:  Bibha Dahal; Caitlin W Lehman; Ivan Akhrymuk; Nicole R Bracci; Lauren Panny; Michael D Barrera; Nishank Bhalla; Jonathan L Jacobs; Jonathan D Dinman; Kylene Kehn-Hall
Journal:  Viruses       Date:  2021-05-12       Impact factor: 5.048

Review 10.  De-Coding the Contributions of the Viral RNAs to Alphaviral Pathogenesis.

Authors:  Autumn T LaPointe; Kevin J Sokoloski
Journal:  Pathogens       Date:  2021-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.